104 related articles for article (PubMed ID: 8353099)
1. Pharmacokinetics and in vitro studies of l-leucovorin. Comparison with the d and d,l-leucovorin.
Zittoun J
Ann Oncol; 1993; 4 Suppl 2():1-5. PubMed ID: 8353099
[TBL] [Abstract][Full Text] [Related]
2. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations.
Bertrand R; Jolivet J
J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil.
Zittoun J; Marquet J; Pilorget JJ; Tonetti C; De Gialluly E
Br J Cancer; 1991 Jun; 63(6):885-8. PubMed ID: 2069845
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
Schilsky RL; Ratain MJ
J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
[TBL] [Abstract][Full Text] [Related]
5. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma.
Meropol NJ; Petrelli NJ; Rustum YM; Rodriguez-Bigas M; Blumenson LE; Frank C; Berghorn E; Creaven PJ
Invest New Drugs; 1995; 13(2):149-55. PubMed ID: 8617578
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
Zhang ZG; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
[TBL] [Abstract][Full Text] [Related]
7. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
Romanini A; Li WW; Colofiore JR; Bertino JR
J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
[TBL] [Abstract][Full Text] [Related]
8. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
Zhang ZG; Rustum YM
Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
[TBL] [Abstract][Full Text] [Related]
9. Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography.
Choi KE; Schilsky RL
Anal Biochem; 1988 Feb; 168(2):398-404. PubMed ID: 2834981
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion.
Newman EM; Straw JA; Doroshow JH
Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of 6R-leucovorin, 6S-leucovorin and 5-methyltetrahydrofolate in human plasma using solid phase extraction and chiral liquid chromatography-tandem mass spectrometry.
Liu K; Dai X; Zhong D; Deng P; Ma J; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):902-10. PubMed ID: 19269903
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D
J Clin Oncol; 1997 Mar; 15(3):908-14. PubMed ID: 9060527
[TBL] [Abstract][Full Text] [Related]
13. Interactions of carboxypeptidase G2 with 6S-leucovorin and 6R-leucovorin in vitro: implications for the application in case of methotrexate intoxications.
Hempel G; Lingg R; Boos J
Cancer Chemother Pharmacol; 2005 Apr; 55(4):347-353. PubMed ID: 15723260
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.
Patel R; Newman EM; Villacorte DG; Sato JK; Reaman GH; Finklestein JZ; Krailo MD; Hammond GD; Holcenberg JS
Cancer Res; 1991 Sep; 51(18):4871-5. PubMed ID: 1893377
[TBL] [Abstract][Full Text] [Related]
15. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
16. Biomodulation of 5-Fu cytotoxicity by folinic acid and its stereoisomers: in vitro experiments with different cell lines of prostatic cancer.
Breul J; Jakse G; Hartung R
Urol Res; 1995; 23(3):163-7. PubMed ID: 7483142
[TBL] [Abstract][Full Text] [Related]
17. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.
Lee PP; Schilsky RL
Cancer Chemother Pharmacol; 1990; 26(4):273-7. PubMed ID: 2114950
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
Miyachi H; Takemura Y; Kobayashi H; Ando Y
Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
